Free Trial

OptimizeRx (OPRX) News Today

OptimizeRx logo
$4.87 +0.38 (+8.46%)
(As of 11/22/2024 ET)
Brokerages Set OptimizeRx Co. (NASDAQ:OPRX) PT at $11.58
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx price target lowered to $8 from $13 at Stifel
OptimizeRx price target lowered to $8 from $16 at JMP Securities
OptimizeRx (OPRX) Gets a Buy from Stifel Nicolaus
OptimizeRx Co. stock logo
OptimizeRx's (OPRX) "Buy" Rating Reiterated at Roth Mkm
Roth Mkm reiterated a "buy" rating and set a $16.00 target price (down previously from $20.00) on shares of OptimizeRx in a research note on Thursday.
OptimizeRx Co. stock logo
Stifel Nicolaus Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $8.00
Stifel Nicolaus decreased their target price on shares of OptimizeRx from $13.00 to $8.00 and set a "buy" rating on the stock in a research note on Thursday.
OptimizeRx Co. stock logo
OptimizeRx (NASDAQ:OPRX) Given New $5.00 Price Target at Barclays
Barclays dropped their price objective on OptimizeRx from $11.00 to $5.00 and set an "equal weight" rating on the stock in a research report on Thursday.
OptimizeRx Co. stock logo
JMP Securities Lowers OptimizeRx (NASDAQ:OPRX) Price Target to $8.00
JMP Securities lowered their price objective on OptimizeRx from $16.00 to $8.00 and set a "market outperform" rating for the company in a research report on Thursday.
OptimizeRx Reports Strong Revenue Growth in Q3 2024
OptimizeRx Reports Third Quarter 2024 Financial Results
Preview: OptimizeRx's Earnings
OptimizeRx Co. stock logo
OptimizeRx (OPRX) Scheduled to Post Quarterly Earnings on Wednesday
OptimizeRx (NASDAQ:OPRX) will be releasing earnings after the market closes on Wednesday, November 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=643153)
OptimizeRx Co. stock logo
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Wednesday
OptimizeRx (NASDAQ:OPRX) will be releasing earnings after the market closes on Wednesday, November 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=643153)
OptimizeRx Co. stock logo
Rice Hall James & Associates LLC Acquires 119,306 Shares of OptimizeRx Co. (NASDAQ:OPRX)
Rice Hall James & Associates LLC raised its holdings in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 24.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 615,441 shares of the company's stock after acquiring an additional 119,306
OptimizeRx Co. stock logo
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Renaissance Technologies LLC
Renaissance Technologies LLC raised its stake in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 101.8% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 142,146 shares of the company's stock after buying an additional 71,700 shares during the perio
OptimizeRx Co. stock logo
First Light Asset Management LLC Purchases 89,377 Shares of OptimizeRx Co. (NASDAQ:OPRX)
First Light Asset Management LLC increased its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 5.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,826,961 shares of the company's stock after ac
OptimizeRx Co. stock logo
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Blair William & Co. IL
Blair William & Co. IL reduced its holdings in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 17.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 643,757 shares of the company's stock after selling 138,816 shares during the qu
OptimizeRx Co. stock logo
Divisadero Street Capital Management LP Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX)
Divisadero Street Capital Management LP lessened its stake in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 16.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,315,913 shares of the company's stock after selling 256,9
OptimizeRx: A Strong Buy on Client Commitments and Growth Potential
OptimizeRx Co. stock logo
Rice Hall James & Associates LLC Has $4.96 Million Holdings in OptimizeRx Co. (NASDAQ:OPRX)
Rice Hall James & Associates LLC increased its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 23.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 496,135 shares of the company's stock after purchas
OptimizeRx Co. stock logo
OptimizeRx (NASDAQ:OPRX) PT Lowered to $14.00 at Royal Bank of Canada
Royal Bank of Canada decreased their price target on shares of OptimizeRx from $17.00 to $14.00 and set an "outperform" rating for the company in a research report on Friday.
OptimizeRx Co. stock logo
OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00
Barclays reduced their target price on shares of OptimizeRx from $15.00 to $11.00 and set an "equal weight" rating for the company in a report on Monday.
OptimizeRx Corporation (OPRX)
OptimizeRx Co. stock logo
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Thursday
OptimizeRx (NASDAQ:OPRX) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=612881)
OptimizeRx Co. stock logo
Q3 2024 Earnings Estimate for OptimizeRx Co. (NASDAQ:OPRX) Issued By B. Riley
OptimizeRx Co. (NASDAQ:OPRX - Free Report) - Research analysts at B. Riley issued their Q3 2024 EPS estimates for OptimizeRx in a research note issued to investors on Wednesday, July 24th. B. Riley analyst K. Bauser anticipates that the company will post earnings of ($0.16) per share for the quar
OptimizeRx Co. stock logo
Equities Analysts Issue Forecasts for OptimizeRx Co.'s Q2 2024 Earnings (NASDAQ:OPRX)
OptimizeRx Co. (NASDAQ:OPRX - Free Report) - B. Riley issued their Q2 2024 earnings estimates for shares of OptimizeRx in a research report issued on Wednesday, July 24th. B. Riley analyst K. Bauser expects that the company will earn ($0.26) per share for the quarter. B. Riley has a "Buy" rating
OptimizeRx Co. stock logo
OptimizeRx (NASDAQ:OPRX) Research Coverage Started at B. Riley
B. Riley started coverage on OptimizeRx in a research note on Thursday. They issued a "buy" rating and a $18.50 price objective on the stock.
OptimizeRx Co. stock logo
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of OptimizeRx Co. (NASDAQ:OPRX - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the co
OptimizeRx Co. stock logo
Essex Investment Management Co. LLC Purchases New Stake in OptimizeRx Co. (NASDAQ:OPRX)
Essex Investment Management Co. LLC bought a new stake in OptimizeRx Co. (NASDAQ:OPRX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm bought 86,656 shares of the company's stock, valued at approximately $1,053,000. Essex Investment Manageme
OptimizeRx Co. stock logo
JMP Securities Reiterates Market Outperform Rating for OptimizeRx (NASDAQ:OPRX)
JMP Securities reaffirmed a "market outperform" rating and issued a $16.00 price objective on shares of OptimizeRx in a research note on Friday.
OptimizeRx Co. stock logo
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by G2 Investment Partners Management LLC
G2 Investment Partners Management LLC boosted its position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 26.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 468,120 shares of the company's stock after purchasing an additional 96,646 share
OptimizeRx Co. stock logo
First Light Asset Management LLC Lowers Holdings in OptimizeRx Co. (NASDAQ:OPRX)
First Light Asset Management LLC decreased its position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 30.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,727,298 shares of the company's stock after selling 758,749 shares during the period. Opt
OptimizeRx Co. stock logo
Avenir Corp Has $1.26 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX)
Avenir Corp trimmed its position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 71.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,260 shares of the company's stock after s
Get OptimizeRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

OPRX Media Mentions By Week

OPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPRX
News Sentiment

0.41

0.63

Average
Computer and Technology
News Sentiment

OPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPRX Articles
This Week

3

2

OPRX Articles
Average Week

Get OptimizeRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners